Literature DB >> 25492997

Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.

Ludovico Abenavoli1, Natasa Milic1, Valentina Peta1, Francesco Alfieri1, Antonino De Lorenzo1, Stefano Bellentani1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. The mechanisms of the underlying disease development and progression are awaiting clarification. Insulin resistance and obesity-related inflammation status, among other possible genetic, dietary, and lifestyle factors, are thought to play the key role. There is no consensus concerning the pharmacological treatment. However, the dietary nutritional management to achieve weight loss is an essential component of any treatment strategy. On the basis of its components, the literature reports on the effectiveness of the Mediterranean diet in reducing cardiovascular risk and in preventing major chronic diseases, including obesity and diabetes. New evidence supports the idea that the Mediterranean diet, associated with physical activity and cognitive behaviour therapy, may have an important role in the prevention and the treatment of NAFLD.

Entities:  

Keywords:  Insulin resistance; Mediterranean diet; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Nutrition

Mesh:

Year:  2014        PMID: 25492997      PMCID: PMC4258553          DOI: 10.3748/wjg.v20.i45.16831

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  81 in total

Review 1.  Evaluating the links between intake of milk/dairy products and cancer.

Authors:  Carlos E A Chagas; Marcelo M Rogero; Lígia A Martini
Journal:  Nutr Rev       Date:  2012-03-27       Impact factor: 7.110

2.  A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome.

Authors:  Jennifer L Jones; Michael Comperatore; Jacqueline Barona; Mariana C Calle; Catherine Andersen; Mark McIntosh; Wadie Najm; Robert H Lerman; Maria Luz Fernandez
Journal:  Metabolism       Date:  2011-09-23       Impact factor: 8.694

3.  Statins and hepatic steatosis: perspectives from the Dallas Heart Study.

Authors:  Jeffrey D Browning
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

4.  NAFLD and hyperinsulinemia are major determinants of serum ferritin levels.

Authors:  Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Zamir Halpern; Ran Oren
Journal:  J Hepatol       Date:  2006-11-07       Impact factor: 25.083

Review 5.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 6.  Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis.

Authors:  Francesco Sofi; Rosanna Abbate; Gian Franco Gensini; Alessandro Casini
Journal:  Am J Clin Nutr       Date:  2010-09-01       Impact factor: 7.045

Review 7.  The Mediterranean diet: the reasons for a success.

Authors:  Marialaura Bonaccio; Licia Iacoviello; Giovanni de Gaetano
Journal:  Thromb Res       Date:  2011-11-17       Impact factor: 3.944

8.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

9.  The diet and 15-year death rate in the seven countries study.

Authors:  A Keys; A Menotti; M J Karvonen; C Aravanis; H Blackburn; R Buzina; B S Djordjevic; A S Dontas; F Fidanza; M H Keys
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

10.  Spanish Ketogenic Mediterranean Diet: a healthy cardiovascular diet for weight loss.

Authors:  Joaquín Pérez-Guisado; Andrés Muñoz-Serrano; Angeles Alonso-Moraga
Journal:  Nutr J       Date:  2008-10-26       Impact factor: 3.271

View more
  40 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals.

Authors:  Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Akihiro Ohbora; Takao Kojima; Michiaki Fukui
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

3.  Polyphenols Treatment in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Ludovico Abenavoli; Natasa Milic; Francesco Luzza; Luigi Boccuto; Antonino De Lorenzo
Journal:  J Transl Int Med       Date:  2017-09-30

4.  Non-alcoholic fatty liver disease and beneficial effects of dietary supplements.

Authors:  Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2015-06-28

5.  Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Authors:  Francesco Baratta; Daniele Pastori; Licia Polimeni; Tommaso Bucci; Fabrizio Ceci; Cinzia Calabrese; Ilaria Ernesti; Gaetano Pannitteri; Francesco Violi; Francesco Angelico; Maria Del Ben
Journal:  Am J Gastroenterol       Date:  2017-10-24       Impact factor: 10.864

Review 6.  Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.

Authors:  Pegah Golabi; Cameron T Locklear; Patrick Austin; Sophie Afdhal; Melinda Byrns; Lynn Gerber; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 7.  Metabolic aspects of adult patients with nonalcoholic fatty liver disease.

Authors:  Ludovico Abenavoli; Natasa Milic; Laura Di Renzo; Tomislav Preveden; Milica Medić-Stojanoska; Antonino De Lorenzo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

Review 8.  Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease.

Authors:  Vikas Gupta; Xian-Jun Mah; Maria Carmela Garcia; Christina Antonypillai; David van der Poorten
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

9.  Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease.

Authors:  Hyun Jung Lee; Jong Eun Yeon; Eun Jung Ko; Eileen L Yoon; Sang Jun Suh; Keunhee Kang; Hae Rim Kim; Seoung Hee Kang; Yang Jae Yoo; Jihye Je; Beom Jae Lee; Ji Hoon Kim; Yeon Seok Seo; Hyung Joon Yim; Kwan Soo Byun
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 10.  Modeling the Western Diet for Preclinical Investigations.

Authors:  Korry J Hintze; Abby D Benninghoff; Clara E Cho; Robert E Ward
Journal:  Adv Nutr       Date:  2018-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.